Fluofarma provides High Content Analysis services for target and drug discovery, predictive toxicity testing and cosmetics development.
Fluofarma’s High Content Analysis platform, based on automated flow cytometry, laser scanning and confocal microscopy, combines cell-based assays with large-scale analysis. Our proprietary High Content Analysis technologies allow a functional analysis of several molecular events simultaneously in single cells.
Fluofarma offers comprehensive High Content Analysis services:
If you need to have further details on our High content analysis services, do not hesitate to contact-us.
FOCUS: Anticancer drugs profiling
Fluofarma has developed DCffer® method, a powerful approach to
compare and profile your anti-cancer drugs. Read
more [+]